Xcout Intel
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. is a biotechnology research company located in Emeryville, California. The company specializes in developing advanced high-fidelity custom DNA synthesis technologies and products.
Subscribe to see Ansa Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ansa Biotechnologies, Inc. at a glance
Ansa Biotechnologies, Inc. is a life sciences company headquartered in United States. It has raised at least $178.6M across the 5 funding rounds on record. Its most recent funding round, Series B, raised $54.4M in October 2025. Xcout tracks 1 named person at Ansa Biotechnologies, Inc., including Jason T. Gammack (Chief Executive Officer). Xcout recorded 18 job postings from Ansa Biotechnologies, Inc. in the last 90 days.
Ansa Biotechnologies, Inc. leadership
- Jason T. GammackChief Executive Officer
Ansa Biotechnologies, Inc. funding rounds
At least $178.6M raised across the 5 rounds on record. The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $54.4M | 7 named | |
| SEC Form D filing | $46.4M | — | |
| SEC Form D filing | $68M | — | |
| SEC Form D filing | $5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Ansa Biotechnologies, Inc.
Xcout recorded 18 job postings from Ansa Biotechnologies, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Ansa Biotechnologies, Inc.'s hiring signals →
Investors
Ansa Biotechnologies, Inc. competitors
A few of Ansa Biotechnologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
Elegen Corp. is a biotechnology company headquartered in Menlo Park, California. The firm specializes in cell-free clonal gene synthesis and produces custom DNA products such as ENFINIA DNA.
Twist Bioscience Corp is headquartered in South San Francisco, California, and operates in the synthetic biology sector. The company manufactures and sells customized DNA synthesis products utilizing a silicon-based platform for various scientific applications.
DNA Script develops enzymatic DNA synthesis technology, offering the SYNTAX platform and associated kits that enable laboratories to produce high-quality oligonucleotides in-house and on-demand. The company serves biotech companies, pharmaceutical firms, contract research organizations, core facilities, and governmental agencies seeking to streamline synthetic biology workflows.
Glyphic Biotechnologies is a biotechnology research company headquartered in Berkeley, California, dedicated to next-generation proteome sequencing and rewriting the rules of proteomics.
4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
Get Ansa Biotechnologies, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ansa Biotechnologies, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ansa Biotechnologies, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access